Summary
Phase: Other
Participating Research Bases-ALLIANCE, COG, ECOG-ACRIN, NRG, SWOG, URCC, WAKE
CANCER TYPE: Any Site
RESEARCH BASE: NCI
BRIEF DESCRIPTION
Screening tool used to collect expanded demographic and clinical data (e.g., SES, co-morbidities, method of diagnosis) across the NCORP network to help identify and best characterize patients that are screened but not enrolled in cancer control studies.
NOTES
All potential study participants must be asked to participate in the screening tool study at the time they are screened for a cancer control or prevention trial.
Patients can be registered to DCP-001 once eligibility for and enrollment status to the trial for which the patient is being screened has been determined.
Patients may still be registered to DCP-001, even if they have been deemed ineligible for the cancer control study.
Participants may be screened for more than one cancer control and prevention trial.
The questionnaire may be accessed under the link for Consent Form 2 above.
The patient script and talking points may be accessed under the link for Consent Form 3 above.
ELIGIBILITY
All patients (pediatric and adults) screened for selected NCORP trials supported by the Division of Cancer Prevention (DCP). These trials include symptom and toxicity management, prevention, screening, post-treatment surveillance and comparative effectiveness. Cancer care delivery clinical trials will be included if the primary aim focuses on a patient intervention. A screened patient will be defined as one meeting the following minimum eligibility criteria per the protocol being screened for:
- Cancer diagnosis including stage and histology or pre-malignancy
- Age range specified in the protocol for which the patient is being screened
- Indication for the study intervention (e.g., symptom, toxicity)
- A legally authorized representative may consent for a participant with impaired decision making.